This article has Open Peer Review reports available.
Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A
© The Author(s). 2017
Received: 14 April 2016
Accepted: 4 April 2017
Published: 19 April 2017
Open Peer Review reports
Pre-publication versions of this article are available by contacting email@example.com.
|14 Apr 2016||Submitted||Original manuscript|
|14 Jul 2016||Reviewed||Reviewer Report - Michele Tavecchio|
|16 Jul 2016||Reviewed||Reviewer Report - Tim Beck|
|16 Jul 2016||Reviewed||Reviewer Report - Lingling Fan|
|16 Jul 2016||Reviewed||Reviewer Report - Dongyin Guan|
|20 Jul 2016||Reviewed||Reviewer Report - Nagio Takigawa|
|25 Jul 2016||Reviewed||Reviewer Report - Yasuyoshi Miyata|
|7 Feb 2017||Author responded||Author comments - Masato Chiba|
|Resubmission - Version 2|
|7 Feb 2017||Submitted||Manuscript version 2|
|4 Apr 2017||Editorially accepted|
|19 Apr 2017||Article published||10.1186/s12885-017-3263-z|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.